🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Status
Completed
Location
Hospital Universitario Príncipe de Asturias
Start Date
2020-11-04
Trial ID
NCT04687761
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
This phase I trial studies the side effects and the best dose of trebananib...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2011-10-31
Trial ID
NCT01555268
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficiency of autol...
Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Start Date
2020-07-27
Trial ID
NCT04499573
Treatments Being Tested
In the proposed study, escalating doses of inotuzumab ozogamicin will be ad...
Status
Unknown
Location
Vanderbilt-Ingram Cancer Center
Start Date
2022-07-22
Trial ID
NCT03962465
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Nottingham City Hospital
Start Date
2006-01
Trial ID
NCT00974792
This phase IB trial studies the feasibility of using a functional laborator...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-13
Trial ID
NCT02779283
Treatments Being Tested
This phase 2 trial studies the efficacy and safety of Avatrombopag for the ...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2021-04
Trial ID
NCT04797182
Treatments Being Tested
The goal of this clinical trial is to show that incorporating ofatumumab in...
Status
Completed
Location
University of California, San Francisco
Start Date
2012-05-25
Trial ID
NCT01555541
Treatments Being Tested
This Phase 1/2 study will evaluate the safety, efficacy, PK, and PD of FT-2...
Status
Completed
Location
UCLA Medical Center
Start Date
2016-04-30
Trial ID
NCT02719574
Treatments Being Tested